Table 1 Characteristics of study participants prior to vaccination.

AllCOVID-19
Recovered
COVID-19
Naive
In-depth analysis
COVID-19 RecoveredCOVID-19 Naive
N12123981312
Gender
Male39 (32.2%)6 (26.1%)33 (35.6%)3 (23%)1 (8.3%)
Female82 (67.8%)17 (73.9%)65 (66.3%)10 (77%)11 (91.7%)
Age404238.54247
(median + Q1-Q3)(34.8-55.8)(34.5-56.5)(34.3-57.3)(34.5-56.5)(34.3-55.0)
< 3021 (17.4%)4 (17.4%)17 (17.3%)3 (23.1%)1 (8.3%)
30-4456 (46.3%)10 (43.5%)46 (46.9%)5 (38.5%)5 (41.7%)
45-5935 (28.9%)7 (30.4%)28 (28.6%)4 (30.8%)5 (41.7%)
> 609 (7.4%)2 (8.7%)7 (7.1%)1 (7.7%)1 (8.3%)
Days between diagnosis and vaccination (median)-54-47-
< 30 days2 (8.7%)2 (15.4%)
30-60 days12 (52.2%)10 (85.6%)
>60 days9 (39.1%)1 (7.7%)